Top Markets
#1 Seeker Seeker +15.40%
#2 Official Trump Official Trump +12.94%
#3 DeFi Kingdoms DeFi Kingdoms +10.56%
#4 Ethena Staked ENA Ethena Staked ENA +9.25%
#5 EXOD EXOD +9.04%
#6 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +8.10%
#7 peaq peaq +7.28%
#8 TDCCP TDCCP +5.86%
#9 Melania Meme Melania Meme +5.55%
#10 Stacks Stacks +5.26%
Coin of the day
Seeker Seeker
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

002399
Xếp hạng trong cổ phiếu #6665
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is an international... Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is an international pharmaceutical enterprise specializing in the production and commercialization of medicinal products. Its operations span Hong Kong, the United States, Europe, Mainland China, and numerous other global markets. The company's business activities are structured into four primary segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization (CDMO), and an 'Others' category. Within its product portfolio, key offerings include finished dose pharmaceuticals, notably enoxaparin sodium injection. Its API division supplies critical ingredients such as heparin sodium API and enoxaparin sodium API, alongside other compounds like pancreatin API. Beyond core products, Hepalink provides a suite of services encompassing research and development, manufacturing, quality management, and program management. This also extends to the creation and production of recombinant pharmaceutical products, essential non-viral vectors, intermediates for gene therapy, and naturally derived pharmaceutical compounds. The group further diversifies its operations into areas such as property management, investment management and consulting, and equity and venture capital. It also engages in biopharmaceutical technology development and consulting, alongside the research, development, and production of biopharmaceuticals. Additional revenue streams include the production and sale of heparin sodium, various pharmaceutical-related service provisions, and the trading of medical and biopharmaceutical products. Established in 1998, the company is headquartered in Shenzhen, People's Republic of China. It adopted its current name, Shenzhen Hepalink Pharmaceutical Group Co., Ltd., in February 2017, having previously operated as Shenzhen Hepalink Pharmaceutical Co.,Ltd.
Giá cổ phiếu
$1.54
Đồng bộ lần cuối: 2026-08-27
Vốn hóa thị trường
$1.92B
Thay đổi (1 ngày)
1.92%
Thay đổi (1 năm)
-14.68%
Quốc gia
CN
Giao dịch Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399)

Danh mục

Healthcare
Lịch sử cổ tức của Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399)
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (mã cổ phiếu: 002399) đã thực hiện tổng cộng 0 lần chi trả cổ tức.
Tổng tất cả cổ tức (đã điều chỉnh theo chia tách cổ phiếu): 0.00
Tỷ suất cổ tức (TTM): 0
Các khoản chi trả cổ tức của Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399) từ 2026 đến 2026
Các khoản chi trả cổ tức hàng năm
Năm Cổ tức (đã điều chỉnh chia tách cổ phiếu) Thay đổi
Không đủ dữ liệu cho ngày được cung cấp.
Danh sách tất cả các khoản chi trả cổ tức
Năm Cổ tức Thay đổi
Không đủ dữ liệu cho ngày được cung cấp.
Cổ tức của các công ty tương tự hoặc đối thủ
Công ty Số lần chi trả cổ tức Quốc gia
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
0.00%
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
0.00%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
0.00%
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
0.00%
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
38.00%
IN